Who Paid My Doc
Mark Clements
Pediatric Endocrinology Kansas City, MO Medical Doctor
NPI 1992902837 CMS profile 420197
2401 Gillham Rd, Kansas City, MO 64108
General payments
$407
Research payments
$921
Ownership & investment interest
$0
Research they led as principal investigator
$475,931
Through program year 2025, Mark Clements of Kansas City, MO is reported in the CMS Open Payments database as having received $407 across 4 general payments and $921 in research payments paid to them. Separately, studies naming them as principal investigator received $475,931 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 58th percentile of Pediatric Endocrinology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | Research | $666 | 4 | |
| 2023 | General | $124 | 1 | |
| 2020 | Research | $255 | 1 | |
| 2019 | General | $282 | 3 |
Beside peers
- Mark Clements
- Pediatric Endocrinology median
- Middle half of Pediatric Endocrinology
- National median
In program year 2025, general payments to Mark Clements were reported at $0. Among 971 Pediatric Endocrinology profiles paid that year, the median was $293 and the middle half received between $106 and $1,640.
Show as a table
| Year | Mark Clements | Pediatric Endocrinology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $282 | $196 | $68–$845 | $163 |
| 2020 | $0 | $124 | $37–$722 | $114 |
| 2021 | $0 | $134 | $35–$691 | $132 |
| 2022 | $0 | $177 | $47–$726 | $149 |
| 2023 | $124 | $236 | $75–$887 | $160 |
| 2024 | $0 | $259 | $91–$979 | $164 |
| 2025 | $0 | $293 | $106–$1,640 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
9 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Endocrinology in Missouri
Ryan McDonough
Pediatric Endocrinology · Kansas City, MO
Joseph Cernich
Pediatric Endocrinology · Kansas City, MO
Neil White
Pediatric Endocrinology · Saint Louis, MO
Matthew Feldt
Pediatric Endocrinology · Kansas City, MO
Myrto Frangos
Pediatric Endocrinology · Chesterfield, MO
Kyle McNerney
Pediatric Endocrinology · Saint Louis, MO
Related records
Pediatric Endocrinology in Missouri
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Endocrinology
Everyone recorded under this specialty, nationwide.
Doctors in Missouri
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.